Ionizable Lipid with Supramolecular Chemistry Features for RNA Delivery In Vivo
Authors:
Open Access
Abstract
Lipid nanoparticles (LNPs) and ribonucleic acid (RNA) technology are highly versatile tools that can be deployed for diagnostic, prophylactic, and therapeutic applications. In this report, supramolecular chemistry concepts are incorporated into the rational design of a new ionizable lipid, C3‐K2‐E14, for systemic administration. This lipid incorporates a cone‐shaped structure intended to facilitate cell bilayer disruption, and three tertiary amines to improve RNA binding. Additionally, hydroxyl and amide motifs are incorporated to further enhance RNA binding and improve LNP stability. Optimization of messenger RNA (mRNA) and small interfering RNA (siRNA) formulation conditions and lipid ratios produce LNPs with favorable diameter (<150 nm), polydispersity index (90%), all of which are preserved after 2 months at 4 or 37 °C storage in ready‐to‐use liquid form. The lipid and formulated LNPs are well‐tolerated in animals and show no deleterious material‐induced effects. Furthermore, 1 week after intravenous LNP administration, fluorescent signal from tagged RNA payloads are not detected. To demonstrate the long‐term treatment potential for chronic diseases, repeated dosing of C3‐K2‐E14 LNPs containing siRNA that silences the colony stimulating factor‐1 (CSF‐1) gene can modulate leukocyte populations in vivo, further highlighting utility.Keywords
Funding Information
- Canada First Research Excellence Fund (CFREF‐2020)
- Canada Research Chairs (CRC‐2020‐00097)
- Natural Sciences and Engineering Research Council of Canada (RGPIN‐2021‐03421)
- Canadian Institutes of Health Research (PTT‐184009)
This publication has 42 references indexed in Scilit:
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- The Role of Nuclear Factor κB in the Interferon ResponseJournal of Interferon & Cytokine Research, 2011
- Nanoparticle PEGylation for Imaging and TherapyNanomedicine, 2011
- The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activationBiomaterials, 2010
- Rational design of cationic lipids for siRNA deliveryNature Biotechnology, 2010
- Lipid-like materials for low-dose, in vivo gene silencingProceedings of the National Academy of Sciences of the United States of America, 2010
- Knocking down barriers: advances in siRNA deliveryNature Reviews Drug Discovery, 2009
- Nonviral delivery of synthetic siRNAs in vivoJournal of Clinical Investigation, 2007
- Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acidsJournal of Controlled Release, 2005
- On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acidsGene Therapy, 2001